Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis

por Verstovsek, S, Atallah, E, Mascarenhas, J, Sun, H, Montgomery, M, Gupta, V, Mesa, R, Gotlib, J
Publicado 2016

P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA

por Kuykendall, A., Kremyanskaya, M., Ginsburg, Y., Pemmaraju, N., Ritchie, E., Gotlib, J., Valone, F., Khanna, S., Gupta, S., Hoffman, R., Verstovsek, S.
Publicado 2022

P1038: CLINICOPATHOLOGIC AND MOLECULAR CORRELATES OF ORGAN DAMAGE ACROSS THE SPECTRUM OF ADVANCED SYSTEMIC MASTOCYTOSIS

por Liang, E., Perkins, C., Lu, R., Shi, H., Dimitrijevic, S., Hoehn, G., Abuel, J., Langford, C., Abidi, P., Fechter, L., Shomali, W., Gotlib, J.
Publicado 2022

Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium

por Tefferi, A, Abdel-Wahab, O, Cervantes, F, Crispino, J D, Finazzi, G, Girodon, F, Gisslinger, H, Gotlib, J, Kiladjian, J-J, Levine, R L, Licht, J D, Mullally, A, Odenike, O, Pardanani, A, Silver, R T, Solary, E, Mughal, T
Publicado 2011

P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

por Reiter, A., Gotlib, J., Álvarez-Twose, I., Radia, D. H., Luebke, J., Bobbili, P. J., Wang, A., Norregaard, C., Dimitrijević, S., Sullivan, E., Louie-Gao, M., Schwaab, J., Galinsky, I. A., Perkins, C., Sperr, W. R., Sriskandarajah, P., Chin, A., Sendhil, S. R., Duh, M. S., Valent, P., DeAngelo, D. J.
Publicado 2022

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE

por Reiter, A., Gotlib, J., Álvarez-Twose, I., Radia, D. H., Luebke, J., Bobbili, P. J., Wang, A., Norregaard, C., Dimitrijević, S., Sullivan, E., Louie-Gao, M., Schwaab, J., Galinsky, I. A., Perkins, C., Sperr, W. R., Sriskandarajah, P., Chin, A., Sendhil, S. R., Duh, M. S., Valent, P., DeAngelo, D. J.
Publicado 2022

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY

por Reiter, A., Gotlib, J., Álvarez-Twose, I., Radia, D. H., Luebke, J., Bobbili, P. J., Wang, A., Norregaard, C., Dimitrijević, S., Sullivan, E., Louie-Gao, M., Schwaab, J., Galinsky, I. A., Perkins, C., Sperr, W. R., Sriskandarajah, P., Chin, A., Sendhil, S. R., Duh, M. S., Valent, P., DeAngelo, D. J.
Publicado 2022

P995: MYELOID NEOPLASMS-ASSOCIATED GENE VARIANTS IN 639 PATIENTS WITH POST-POLYCYTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS: AN ANALYSIS OF THE MYSEC COHORT

por Mora, B., Guglielmelli, P., Kuykendall, A., Maffioli, M., Rotunno, G., Komrokji, R. S., Palandri, F., Kiladjian, J.-J., Iurlo, A., Auteri, G., Cattaneo, D., De Stefano, V., Salmoiraghi, S., Devos, T., Cervantes, F., Merli, M., Campagna, A., Benevolo, G., Brociner, M., Albano, F., Gotlib, J., Caramella, M., Ruggeri, M., Ross, D. M., Orsini, F., Pessina, C., Colugnat, I., Pallotti, F., Barbui, T., Bertù, L., Della Porta, M. G., Vannucchi, A. M., Passamonti, F.
Publicado 2022